Skip to main content

Anemia Prior to Surgery News

FDA Approves Retacrit (epoetin alfa-epbx) as First Epoetin Alfa Biosimilar for the Treatment of Anemia

May 15, 2018 – The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Anemia